Daiichi Sankyo’s pexidartinib has become the first FDA-approved therapy for tenosynovial giant cell tumour (TGCT), a rare form of tumour affecting joints and tendons. TGCT – which is also ...
MyChesCo on MSN7h
NCCN Launches Free On-Demand Webinar on Cancer Clinical TrialsThe National Comprehensive Cancer Network® (NCCN®) has released a free, on-demand webinar titled “Why Should I Consider a ...
Zacks Investment Research on MSN8h
Merck Loses Almost $52B in 6 Months: How to Play MRK StockThe stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market value The numerous ...
DelveInsight's Molecular Glues Market Insights report includes a comprehensive understanding of current treatment practices, ...
The recent approvals and robust pipeline activity are expected to fuel the market of molecular glues in the 7MM during the forecast period 2025-2034 due to factors like improved diagnosis, treatment ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback